147 related articles for article (PubMed ID: 8539450)
21. Pretreatment apoptotic scores do not predict response to radiation therapy in oropharyngeal squamous cell carcinoma.
Tsuchiya K; Shirato H; Nishioka T; Yamazaki A; Hashimoto S; Kagei K; Oomori K; Yasuda M; Shindo M; Miyasaka K
Oral Oncol; 2001 Feb; 37(2):159-63. PubMed ID: 11167143
[TBL] [Abstract][Full Text] [Related]
22. Transient increases of growth fraction during fractionated radiation therapy for cervical carcinoma. Ki-67 and PC10 immunostaining.
Oka K; Nakano T; Hoshi T
Cancer; 1993 Nov; 72(9):2621-7. PubMed ID: 8402484
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.
Loncaster JA; Cooper RA; Logue JP; Davidson SE; Hunter RD; West CM
Br J Cancer; 2000 Sep; 83(5):620-5. PubMed ID: 10944602
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant chemotherapy in cervical carcinoma: regulators of cell cycle, apoptosis, and proliferation as determinants of response to therapy and disease outcome.
Costa S; Terzano P; Santini D; Ceccarelli C; Martoni A; Angelelli B; Panetta A; Bovicelli A; Cristiani P; Lipponen P; Erzén M; Syrjänen S; Syrjänen K
Am J Clin Pathol; 2001 Nov; 116(5):729-37. PubMed ID: 11710691
[TBL] [Abstract][Full Text] [Related]
25. Ki-67 expression predicts radiosensitivity in oral squamous cell carcinoma.
Freudlsperger C; Freier K; Hoffmann J; Engel M
Int J Oral Maxillofac Surg; 2012 Aug; 41(8):965-9. PubMed ID: 22591716
[TBL] [Abstract][Full Text] [Related]
26. Differential values of Ki-67 index and mitotic index of proliferating cell population. An assessment of cell cycle and prognosis in radiation therapy for cervical cancer.
Nakano T; Oka K
Cancer; 1993 Oct; 72(8):2401-8. PubMed ID: 8402456
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis in cervical squamous carcinoma: predictive value for survival following radiotherapy.
Paxton JR; Bolger BS; Armour A; Symonds RP; Mao JH; Burnett RA
J Clin Pathol; 2000 Mar; 53(3):197-200. PubMed ID: 10823138
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumour oxygenation during radiotherapy.
Sheridan MT; West CM; Cooper RA; Stratford IJ; Logue JP; Davidson SE; Hunter RD
Br J Cancer; 2000 Mar; 82(6):1177-82. PubMed ID: 10735502
[TBL] [Abstract][Full Text] [Related]
29. Proliferation to apoptosis ratio as a prognostic marker in adenocarcinoma of uterine cervix.
Leung TW; Xue WC; Cheung AN; Khoo US; Ngan HY
Gynecol Oncol; 2004 Mar; 92(3):866-72. PubMed ID: 14984954
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.
Tsang RW; Juvet S; Pintilie M; Hill RP; Wong CS; Milosevic M; Chapman W; Levin W; Manchul LA; Fykes AW
Clin Cancer Res; 2003 Oct; 9(12):4387-95. PubMed ID: 14555510
[TBL] [Abstract][Full Text] [Related]
31. Inherent radiosensitivity testing of tumor biopsies obtained from patients with carcinoma of the cervix or endometrium.
Allalunis-Turner MJ; Pearcey RG; Barron GM; Buryn DA; Babiak JC; Honoré LH
Radiother Oncol; 1991 Nov; 22(3):201-5. PubMed ID: 1771262
[TBL] [Abstract][Full Text] [Related]
32. p53 and Ki-67 as predictive markers for radiosensitivity in squamous cell carcinoma of the oral cavity? an immunohistochemical and clinicopathologic study.
Koelbl O; Rosenwald A; Haberl M; Müller J; Reuther J; Flentje M
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):147-54. PubMed ID: 11163508
[TBL] [Abstract][Full Text] [Related]
33. Proliferative index activity in oral squamous cell carcinoma: indication for postoperative radiotherapy?
Gontarz M; Wyszyńska-Pawelec G; Zapała J; Czopek J; Lazar A; Tomaszewska R
Int J Oral Maxillofac Surg; 2014 Oct; 43(10):1189-94. PubMed ID: 24814691
[TBL] [Abstract][Full Text] [Related]
34. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
Yeh SA; Wan Leung S; Wang CJ; Chen HC
Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
[TBL] [Abstract][Full Text] [Related]
35. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
[TBL] [Abstract][Full Text] [Related]
36. Potential application of the ATP cell viability assay in the measurement of intrinsic radiosensitivity in cervical cancer.
Tam KF; Ng TY; Liu SS; Tsang PC; Kwong PW; Ngan HY
Gynecol Oncol; 2005 Mar; 96(3):765-70. PubMed ID: 15721424
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer.
Burcombe R; Wilson GD; Dowsett M; Khan I; Richman PI; Daley F; Detre S; Makris A
Breast Cancer Res; 2006; 8(3):R31. PubMed ID: 16790076
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
Hille A; Weiss E; Hess CF
Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
[TBL] [Abstract][Full Text] [Related]
39. The prognostic significance of tumour cell proliferation in squamous cell carcinomas of the oesophagus.
Sarbia M; Bittinger F; Porschen R; Dutkowski P; Torzewski M; Willers R; Gabbert HE
Br J Cancer; 1996 Oct; 74(7):1012-6. PubMed ID: 8855967
[TBL] [Abstract][Full Text] [Related]
40. Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity.
Davidson SE; West CM; Roberts SA; Hendry JH; Hunter RD
Radiother Oncol; 1990 Aug; 18(4):349-56. PubMed ID: 2244021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
